These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12530939)

  • 1. Molecular mechanisms of angiotensin II-induced vascular injury.
    Ruiz-Ortega M; Ruperez M; Esteban V; Egido J
    Curr Hypertens Rep; 2003 Feb; 5(1):73-9. PubMed ID: 12530939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of angiotensin II in regulating vascular structural and functional changes in hypertension.
    Touyz RM
    Curr Hypertens Rep; 2003 Apr; 5(2):155-64. PubMed ID: 12642016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II as a pro-inflammatory mediator.
    Phillips MI; Kagiyama S
    Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II.
    Touyz RM
    Exp Physiol; 2005 Jul; 90(4):449-55. PubMed ID: 15890798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients.
    Touyz RM; He G; Wu XH; Park JB; Mabrouk ME; Schiffrin EL
    Hypertension; 2001 Jul; 38(1):56-64. PubMed ID: 11463760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II signal transduction in vascular smooth muscle cells: role of tyrosine kinases.
    Ishida M; Berk BC
    Keio J Med; 1997 Jun; 46(2):61-8. PubMed ID: 9212588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease.
    Touyz RM
    Braz J Med Biol Res; 2004 Aug; 37(8):1263-73. PubMed ID: 15273829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.
    Kim S; Iwao H
    Pharmacol Rev; 2000 Mar; 52(1):11-34. PubMed ID: 10699153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms.
    Ruiz-Ortega M; Lorenzo O; Rupérez M; König S; Wittig B; Egido J
    Circ Res; 2000 Jun; 86(12):1266-72. PubMed ID: 10864918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle.
    Tallant EA; Diz DI; Ferrario CM
    Hypertension; 1999 Oct; 34(4 Pt 2):950-7. PubMed ID: 10523390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular fibrosis in atherosclerosis.
    Lan TH; Huang XQ; Tan HM
    Cardiovasc Pathol; 2013; 22(5):401-7. PubMed ID: 23375582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms.
    Deguchi J; Makuuchi M; Nakaoka T; Collins T; Takuwa Y
    Circ Res; 1999 Oct; 85(7):565-74. PubMed ID: 10506481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways.
    Touyz RM; Schiffrin EL
    Hypertension; 1997 Aug; 30(2 Pt 1):222-9. PubMed ID: 9260984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery.
    Kim S; Izumi Y; Yano M; Hamaguchi A; Miura K; Yamanaka S; Miyazaki H; Iwao H
    Circulation; 1998 May; 97(17):1731-7. PubMed ID: 9591768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II signal transduction and the mitogen-activated protein kinase pathway.
    Duff JL; Marrero MB; Paxton WG; Schieffer B; Bernstein KE; Berk BC
    Cardiovasc Res; 1995 Oct; 30(4):511-7. PubMed ID: 8574999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats.
    Touyz RM; He G; El Mabrouk M; Diep Q; Mardigyan V; Schiffrin EL
    J Hypertens; 2001 Mar; 19(3 Pt 2):553-9. PubMed ID: 11327629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases.
    Berk BC; Corson MA
    Circ Res; 1997 May; 80(5):607-16. PubMed ID: 9130441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in intracellular signalling in hypertension.
    Touyz RM
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):165-74. PubMed ID: 12589177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin and the regulation of cellular growth. Pathophysiologic implications for cardiovascular and noncardiovascular tissues.
    Re R
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):217S-219S. PubMed ID: 1710467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.
    Dostal DE; Hunt RA; Kule CE; Bhat GJ; Karoor V; McWhinney CD; Baker KM
    J Mol Cell Cardiol; 1997 Nov; 29(11):2893-902. PubMed ID: 9405164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.